Nicotin ES Tablet 1 mg (Varenicline Salicylate)
Varenicline Salicylate 1.65mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
MFDS item code 202003083 · Approved 2020.04.27
This product's status changed to Approval withdrawn on 2024.12.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Smoking cessation support
The adjunct therapy for smoking cessation helps individuals who want to quit smoking to increase their chances of success. This therapy uses nicotine substitutes or medications to alleviate withdrawal symptoms and reduce the discomfort associated with quitting smoking. It also offers psychological support through behavioral therapy and counseling, helping to control cravings and maintain healthy lifestyle habits. The adjunct therapy plays an important role in achieving smoking cessation.
After dose titration over 1 week, administer 1 mg twice daily. Days 1–3: 0.5 mg once daily Days 4–7: 0.5 mg twice daily Day 8 until end of treatment: 1 mg twice daily In patients who cannot tolerate the adverse reactions of this medicine, the dose may be reduced temporarily or permanently. The treatment period with this medicine is 12 weeks. For patients who successfully quit smoking with the first 12 weeks of treatment, an additional 12 weeks of treatment with this medicine is recommended to increase the likelihood of long-term abstinence. Continue treatment with this medicine for an additional 12 weeks, for a total treatment period of 24 weeks. No dosage adjustment is necessary in patients with mild (estimated creatinine clearance > 50 mL/min and ≤ 80 mL/min) to moderate (estimated creatinine clearance ≥ 30 mL/min and ≤ 50 mL/min) renal impairment. In patients with severe renal impairment (estimated creatinine clearance < 30 mL/min), the recommended starting dose of varenicline is 0.5 mg once daily. If necessary, the dose may be increased to a maximum of 0.5 mg twice daily. In patients with end-stage renal disease receiving hemodialysis, if well tolerated, the maximum dose is 0.5 mg once daily. No dosage adjustment is necessary in patients with hepatic impairment.
Under 18 years: The safety and efficacy of this medicine have not been established in children; therefore, use in patients under 18 years of age is not recommended.
This medication is intended to assist with smoking cessation, and serious neuropsychiatric symptoms may occur during treatment, so caution is needed. If there is a history of psychiatric disorders, it is essential to inform your doctor before taking this medication, and if symptoms such as depression, anxiety, or suicidal thoughts occur during treatment, discontinue use immediately and consult a doctor. This medication should not be used in patients with hypersensitivity, and caution should be exercised in pregnant or breastfeeding women. The most common side effect is nausea, which is generally mild, but may persist in some patients. Additionally, quitting smoking itself can trigger various symptoms such as depression, insomnia, and anxiety, so care should be taken if these symptoms occur during treatment. This medication may increase the risk of seizures, so patients with a history of seizures or risk factors for seizures should consult a doctor before use. Caution is advised for activities requiring attention, such as driving or operating machinery, after taking this medication. Alcohol consumption may exacerbate side effects, so it is advised to avoid or minimize alcohol intake during treatment. This medication is excreted through the kidneys, so dosage adjustments may be necessary for patients with reduced kidney function, especially for the elderly. There is no specific antidote for overdose, so appropriate treatment should be received based on symptoms, and keep out of reach of children.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect from air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a long time.
Light blue, convex-shaped, film-coated tablets
28 tablets (14 tablets/PTP X 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Varenicline Salicylate 1.65mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Varenicline Salicylate 0.825mg
Tablet · Prescription medication
McNulty Pharmaceuticals Co., Ltd.

Varenicline Salicylate 1.65mg
Tablet · Prescription medication
McNulty Pharma Co., Ltd.

Varenicline Salicylate 1.65mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Varenicline Salicylate 0.825mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.
Varenicline Salicylate
Prescription medication
Korea Pavice Pharmaceuticals Co., Ltd.
Varenicline Salicylate
Prescription medication
HanKook Pavis Pharmaceutical Co., Ltd.
Varenicline Salicylate
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.